Mirabegron 25mg ER Tablets
Overview
What is this medicine?
How to Use This Medicine
To ensure you get the most benefit from your medication, follow these steps:
Take your medication exactly as directed by your doctor.
Read all the information provided with your medication and follow the instructions carefully.
For all patients:
+ Swallow the tablets whole; do not chew, break, or crush them.
+ Take the medication with a full glass of water.
Adults: You can take the medication with or without food.
Children: Give the medication to children with food.
Storing and Disposing of Your Medication
To keep your medication safe and effective:
Store it at room temperature in a dry place, avoiding the bathroom.
Keep all medications in a secure location, out of the reach of children and pets.
Dispose of unused or expired medications properly. Do not flush them down the toilet or pour them down the drain unless instructed to do so by your pharmacist.
If you have questions about disposing of your medication, consult your pharmacist. You may also have access to drug take-back programs in your area.
What to Do If You Miss a Dose
If you miss a dose, follow these guidelines:
Take the missed dose as soon as you remember.
If it has been 12 hours or more since the missed dose, skip the missed dose and resume your regular dosing schedule.
Do not take two doses at the same time or take extra doses to make up for the missed dose.
Lifestyle & Tips
- Take the tablet whole with water; do not chew, crush, or divide it.
- Can be taken with or without food.
- Continue with bladder training exercises and fluid management as advised by your doctor.
- Report any significant increase in blood pressure or difficulty urinating to your doctor.
Available Forms & Alternatives
Available Strengths:
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of a urinary tract infection (UTI), including:
+ Blood in the urine
+ Burning or pain when passing urine
+ Frequent or urgent need to urinate
+ Fever
+ Lower stomach pain
+ Pelvic pain
Signs of high blood pressure, such as:
+ Severe headache
+ Dizziness
+ Fainting
+ Changes in eyesight
Fast heartbeat
Difficulty passing urine
Bladder irritation
Angioedema, a severe reaction that may be life-threatening, characterized by:
+ Swelling of the hands, face, lips, eyes, tongue, or throat
+ Trouble breathing
+ Trouble swallowing
+ Unusual hoarseness
Other Possible Side Effects
Most people taking this medication will not experience side effects, or they may be mild. However, if you notice any of the following side effects, or if they bother you or do not go away, contact your doctor:
Headache
Nose or throat irritation
Dry mouth
* Constipation
This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Sudden, severe increase in blood pressure (e.g., severe headache, blurred vision)
- Difficulty urinating or feeling of incomplete bladder emptying
- Swelling of the face, lips, tongue, or throat (signs of angioedema)
- Chest pain or irregular heartbeat
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
Certain health conditions, including:
+ Kidney disease
+ Liver disease
+ High blood pressure
This list is not exhaustive, and it is crucial to discuss all your health problems with your doctor.
Additionally, provide your doctor and pharmacist with a comprehensive list of all the medications you are taking, including:
Prescription medications
Over-the-counter (OTC) medications
Natural products
Vitamins
It is vital to verify that it is safe to take this medication with all your other medications and health conditions. Never start, stop, or change the dose of any medication without first consulting your doctor.
Precautions & Cautions
As this medication can cause high blood pressure, it is crucial to have your blood pressure monitored as directed by your doctor. If you are pregnant, planning to become pregnant, or are currently breast-feeding, you must discuss this with your doctor. This discussion will help you understand the benefits and risks associated with taking this medication during pregnancy or breast-feeding, allowing you to make an informed decision about your care and the well-being of your baby.
Overdose Information
Overdose Symptoms:
- Palpitations
- Increased pulse rate
- Increased blood pressure
What to Do:
Treatment should be symptomatic and supportive. Monitor heart rate, blood pressure, and ECG. Call 1-800-222-1222 (Poison Control Center) or seek emergency medical attention.
Drug Interactions
Major Interactions
- Digoxin (increased digoxin levels, monitor)
- CYP2D6 substrates with narrow therapeutic index (e.g., flecainide, propafenone, thioridazine, desipramine, metoprolol - increased exposure of these drugs)
Moderate Interactions
- Warfarin (potential for increased INR, monitor)
- Other P-gp substrates (potential for increased exposure)
Confidence Interactions
Monitoring
Baseline Monitoring
Rationale: Mirabegron can increase blood pressure. Patients with severe uncontrolled hypertension (systolic blood pressure âĨ 180 mm Hg or diastolic blood pressure âĨ 110 mm Hg) should not take mirabegron.
Timing: Prior to initiation of therapy
Routine Monitoring
Frequency: Periodically
Target: Maintain within patient's target range, typically <140/90 mmHg
Action Threshold: If significant increase or uncontrolled hypertension develops, consider dose reduction or discontinuation.
Frequency: Regularly
Target: Absence of symptoms
Action Threshold: If symptoms of bladder outlet obstruction or urinary retention develop, discontinue mirabegron and seek medical attention.
Symptom Monitoring
- Changes in blood pressure (headache, dizziness, blurred vision)
- Signs of urinary retention (difficulty urinating, weak stream, feeling of incomplete emptying)
- Symptoms of angioedema (swelling of face, lips, tongue, throat)
- Worsening of OAB symptoms
Special Patient Groups
Pregnancy
Mirabegron is Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus.
Trimester-Specific Risks:
Lactation
Mirabegron is excreted in the milk of rats. It is unknown whether mirabegron is excreted in human milk. A decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.
Pediatric Use
Safety and effectiveness in pediatric patients have not been established. Not recommended for use in this population.
Geriatric Use
No dose adjustment is required based on age alone. However, elderly patients may have reduced renal or hepatic function, which may necessitate dose adjustment as per impairment guidelines. Higher incidence of hypertension observed in elderly patients in clinical trials.
Clinical Information
Clinical Pearls
- Mirabegron is an alternative to anticholinergic agents for OAB, particularly useful for patients who cannot tolerate anticholinergic side effects (e.g., dry mouth, constipation, cognitive impairment).
- Monitor blood pressure regularly, especially in patients with pre-existing hypertension.
- Patients with bladder outlet obstruction or those taking antimuscarinic medications for OAB should be monitored for signs of urinary retention.
- Full therapeutic effect may take several weeks (up to 8 weeks) to be observed, so patients should be advised to continue therapy as prescribed.
Alternative Therapies
- Anticholinergic agents (e.g., oxybutynin, tolterodine, solifenacin, darifenacin, fesoterodine)
- OnabotulinumtoxinA (Botox) intravesical injection
- Sacral neuromodulation
- Percutaneous tibial nerve stimulation (PTNS)
- Behavioral therapies (e.g., bladder training, pelvic floor muscle exercises)